Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-03-05

AUTHORS

A Igarashi, K Kakihana, K Haraguchi, J Aoki, T Kobayashi, Y Okuyama, K Ohashi, H Sakamaki

ABSTRACT

We retrospectively analyzed the association between anti-host isohemagglutinin (IH) production and the development of acute GVHD. Of 189 patients who received minor or major/minor ABO-incompatible hematopoietic SCT (HSCT) at our hospital, 36 patients (19%) showed IH production. IH was detected before the onset of acute GVHD in 10, around the same time in 8, and after the onset of acute GVHD in 17 patients. The cumulative incidence of grade II–IV acute GVHD was significantly higher in the IH+ group compared with the IH− group (P<0.0001). The higher risk of acute GVHD that was associated with IH production occurred irrespective of human leukocyte Ag compatibility and donor type. Furthermore, the incidence of acute GVHD in the IH− group was comparable to that seen in major ABO-incompatible or -compatible HSCT. Our findings not only showed a strong association between IH production and acute GVHD development, but also suggested that IH production might be a useful predictor of subsequent acute GVHD after ABO-incompatible HSCT. More... »

PAGES

1356-1360

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2012.32

DOI

http://dx.doi.org/10.1038/bmt.2012.32

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027235754

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22388282


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ABO Blood-Group System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemagglutinins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Igarashi", 
        "givenName": "A", 
        "id": "sg:person.0643633551.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643633551.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakihana", 
        "givenName": "K", 
        "id": "sg:person.0677710136.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677710136.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haraguchi", 
        "givenName": "K", 
        "id": "sg:person.0644344774.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644344774.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aoki", 
        "givenName": "J", 
        "id": "sg:person.01264262573.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264262573.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayashi", 
        "givenName": "T", 
        "id": "sg:person.01355201036.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okuyama", 
        "givenName": "Y", 
        "id": "sg:person.01243551065.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243551065.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohashi", 
        "givenName": "K", 
        "id": "sg:person.016213765552.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016213765552.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakamaki", 
        "givenName": "H", 
        "id": "sg:person.01143751601.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143751601.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1704816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039667048", 
          "https://doi.org/10.1038/sj.bmt.1704816"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-03-05", 
    "datePublishedReg": "2012-03-05", 
    "description": "We retrospectively analyzed the association between anti-host isohemagglutinin (IH) production and the development of acute GVHD. Of 189 patients who received minor or major/minor ABO-incompatible hematopoietic SCT (HSCT) at our hospital, 36 patients (19%) showed IH production. IH was detected before the onset of acute GVHD in 10, around the same time in 8, and after the onset of acute GVHD in 17 patients. The cumulative incidence of grade II\u2013IV acute GVHD was significantly higher in the IH+ group compared with the IH\u2212 group (P<0.0001). The higher risk of acute GVHD that was associated with IH production occurred irrespective of human leukocyte Ag compatibility and donor type. Furthermore, the incidence of acute GVHD in the IH\u2212 group was comparable to that seen in major ABO-incompatible or -compatible HSCT. Our findings not only showed a strong association between IH production and acute GVHD development, but also suggested that IH production might be a useful predictor of subsequent acute GVHD after ABO-incompatible HSCT.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bmt.2012.32", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "keywords": [
      "acute GVHD", 
      "hematopoietic SCT", 
      "isohemagglutinin production", 
      "high risk", 
      "acute GVHD development", 
      "subsequent acute GVHD", 
      "ABO-incompatible transplantation", 
      "GVHD development", 
      "cumulative incidence", 
      "major ABO", 
      "grade II", 
      "GVHD", 
      "donor type", 
      "patients", 
      "strong association", 
      "useful predictor", 
      "incidence", 
      "risk", 
      "onset", 
      "association", 
      "group", 
      "transplantation", 
      "hospital", 
      "ABO", 
      "SCT", 
      "predictors", 
      "findings", 
      "IH", 
      "production", 
      "development", 
      "types", 
      "time", 
      "same time", 
      "compatibility", 
      "anti-host isohemagglutinin (IH) production", 
      "minor ABO-incompatible hematopoietic SCT", 
      "ABO-incompatible hematopoietic SCT", 
      "IH production", 
      "human leukocyte Ag compatibility", 
      "leukocyte Ag compatibility", 
      "Ag compatibility"
    ], 
    "name": "Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation", 
    "pagination": "1356-1360", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027235754"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2012.32"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22388282"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2012.32", 
      "https://app.dimensions.ai/details/publication/pub.1027235754"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_567.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bmt.2012.32"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2012.32'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2012.32'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2012.32'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2012.32'


 

This table displays all metadata directly associated to this object as RDF triples.

222 TRIPLES      22 PREDICATES      84 URIs      75 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2012.32 schema:about N010aff51a9224b378f8a115c2038ec65
2 N028e24ebd708479396e4a87323dbf146
3 N0c21bf8fab1a4920abcf5a48700e8f10
4 N1933fe1c492d47989d7c4e6b2a3a20c3
5 N1950d6b50104413a88d760680ec5d802
6 N2fe80e3b16464fd29ddd8114ef59275c
7 N34a1e6a820d1483dac7bb40576209423
8 N3612da2ad00a4ad0b7f4ea4eec5e75fe
9 N3fabf2d9799f44f69146180290730ed5
10 N58229117cc7b43f8a5373d51bb2d785a
11 N5e56153fbd594eb58676fcc146901dc3
12 N9963a126298c4f598ff2e489354ba7c5
13 Nb0395076b03b4935a7a3ef1f176948be
14 Nb6c8c149d9574b039ed28848e03c8e95
15 Ncf3af38ae81a461081581ab5e747d296
16 Nf2fba5c80aa543b0b2a09a12ed5ea2e3
17 anzsrc-for:11
18 anzsrc-for:1107
19 schema:author Nf6f569ecf8dc4c32b4c079036f2ad8e4
20 schema:citation sg:pub.10.1038/sj.bmt.1704816
21 schema:datePublished 2012-03-05
22 schema:datePublishedReg 2012-03-05
23 schema:description We retrospectively analyzed the association between anti-host isohemagglutinin (IH) production and the development of acute GVHD. Of 189 patients who received minor or major/minor ABO-incompatible hematopoietic SCT (HSCT) at our hospital, 36 patients (19%) showed IH production. IH was detected before the onset of acute GVHD in 10, around the same time in 8, and after the onset of acute GVHD in 17 patients. The cumulative incidence of grade II–IV acute GVHD was significantly higher in the IH+ group compared with the IH− group (P<0.0001). The higher risk of acute GVHD that was associated with IH production occurred irrespective of human leukocyte Ag compatibility and donor type. Furthermore, the incidence of acute GVHD in the IH− group was comparable to that seen in major ABO-incompatible or -compatible HSCT. Our findings not only showed a strong association between IH production and acute GVHD development, but also suggested that IH production might be a useful predictor of subsequent acute GVHD after ABO-incompatible HSCT.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N06ab3591092542108f3fe27612ca95e1
28 Na00ae380e10c49b7be12361f47f4efe4
29 sg:journal.1096890
30 schema:keywords ABO
31 ABO-incompatible hematopoietic SCT
32 ABO-incompatible transplantation
33 Ag compatibility
34 GVHD
35 GVHD development
36 IH
37 IH production
38 SCT
39 acute GVHD
40 acute GVHD development
41 anti-host isohemagglutinin (IH) production
42 association
43 compatibility
44 cumulative incidence
45 development
46 donor type
47 findings
48 grade II
49 group
50 hematopoietic SCT
51 high risk
52 hospital
53 human leukocyte Ag compatibility
54 incidence
55 isohemagglutinin production
56 leukocyte Ag compatibility
57 major ABO
58 minor ABO-incompatible hematopoietic SCT
59 onset
60 patients
61 predictors
62 production
63 risk
64 same time
65 strong association
66 subsequent acute GVHD
67 time
68 transplantation
69 types
70 useful predictor
71 schema:name Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation
72 schema:pagination 1356-1360
73 schema:productId N0152e0becce54bed9cf19f83bc72b7de
74 N71302caf9a8a4ab3b9f88a794ab436e1
75 N8f7c0c1e3e5b4028ae7fbc4569246944
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027235754
77 https://doi.org/10.1038/bmt.2012.32
78 schema:sdDatePublished 2022-01-01T18:28
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher Nfebc8af85ba84e1d80875eb3008821e1
81 schema:url https://doi.org/10.1038/bmt.2012.32
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N010aff51a9224b378f8a115c2038ec65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Risk Factors
87 rdf:type schema:DefinedTerm
88 N0152e0becce54bed9cf19f83bc72b7de schema:name doi
89 schema:value 10.1038/bmt.2012.32
90 rdf:type schema:PropertyValue
91 N028e24ebd708479396e4a87323dbf146 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Graft vs Host Disease
93 rdf:type schema:DefinedTerm
94 N06ab3591092542108f3fe27612ca95e1 schema:volumeNumber 47
95 rdf:type schema:PublicationVolume
96 N0c21bf8fab1a4920abcf5a48700e8f10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Aged
98 rdf:type schema:DefinedTerm
99 N1933fe1c492d47989d7c4e6b2a3a20c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 N1950d6b50104413a88d760680ec5d802 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Hemagglutinins
104 rdf:type schema:DefinedTerm
105 N2b50921d9afd441d80d417c6c3b0e49d rdf:first sg:person.0644344774.08
106 rdf:rest Ndf5efbc0ec0f4225bb73d7d4058b86a9
107 N2fe80e3b16464fd29ddd8114ef59275c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N34a1e6a820d1483dac7bb40576209423 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Middle Aged
112 rdf:type schema:DefinedTerm
113 N3612da2ad00a4ad0b7f4ea4eec5e75fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hematopoietic Stem Cell Transplantation
115 rdf:type schema:DefinedTerm
116 N3dffe2f3e3da4afcb4d15858cadc52f0 rdf:first sg:person.016213765552.09
117 rdf:rest N448ca41ae40942bf84977600697cf62e
118 N3fabf2d9799f44f69146180290730ed5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Retrospective Studies
120 rdf:type schema:DefinedTerm
121 N448ca41ae40942bf84977600697cf62e rdf:first sg:person.01143751601.01
122 rdf:rest rdf:nil
123 N58229117cc7b43f8a5373d51bb2d785a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Adolescent
125 rdf:type schema:DefinedTerm
126 N5e56153fbd594eb58676fcc146901dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Male
128 rdf:type schema:DefinedTerm
129 N71302caf9a8a4ab3b9f88a794ab436e1 schema:name pubmed_id
130 schema:value 22388282
131 rdf:type schema:PropertyValue
132 N79175770ac424a7ca0137e05963332f8 rdf:first sg:person.01243551065.00
133 rdf:rest N3dffe2f3e3da4afcb4d15858cadc52f0
134 N8f7c0c1e3e5b4028ae7fbc4569246944 schema:name dimensions_id
135 schema:value pub.1027235754
136 rdf:type schema:PropertyValue
137 N9963a126298c4f598ff2e489354ba7c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name ABO Blood-Group System
139 rdf:type schema:DefinedTerm
140 N99d2cfb5e91a42c492e6ea63042a5583 rdf:first sg:person.01355201036.66
141 rdf:rest N79175770ac424a7ca0137e05963332f8
142 Na00ae380e10c49b7be12361f47f4efe4 schema:issueNumber 10
143 rdf:type schema:PublicationIssue
144 Nb0395076b03b4935a7a3ef1f176948be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Acute Disease
146 rdf:type schema:DefinedTerm
147 Nb6c8c149d9574b039ed28848e03c8e95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Hematologic Neoplasms
149 rdf:type schema:DefinedTerm
150 Nc5443fea9e314157ba7ae1dcd33a360d rdf:first sg:person.0677710136.43
151 rdf:rest N2b50921d9afd441d80d417c6c3b0e49d
152 Ncf3af38ae81a461081581ab5e747d296 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Isoantibodies
154 rdf:type schema:DefinedTerm
155 Ndf5efbc0ec0f4225bb73d7d4058b86a9 rdf:first sg:person.01264262573.40
156 rdf:rest N99d2cfb5e91a42c492e6ea63042a5583
157 Nf2fba5c80aa543b0b2a09a12ed5ea2e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Female
159 rdf:type schema:DefinedTerm
160 Nf6f569ecf8dc4c32b4c079036f2ad8e4 rdf:first sg:person.0643633551.26
161 rdf:rest Nc5443fea9e314157ba7ae1dcd33a360d
162 Nfebc8af85ba84e1d80875eb3008821e1 schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
168 schema:name Immunology
169 rdf:type schema:DefinedTerm
170 sg:journal.1096890 schema:issn 0268-3369
171 1476-5365
172 schema:name Bone Marrow Transplantation
173 schema:publisher Springer Nature
174 rdf:type schema:Periodical
175 sg:person.01143751601.01 schema:affiliation grid-institutes:grid.415479.a
176 schema:familyName Sakamaki
177 schema:givenName H
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143751601.01
179 rdf:type schema:Person
180 sg:person.01243551065.00 schema:affiliation grid-institutes:grid.415479.a
181 schema:familyName Okuyama
182 schema:givenName Y
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243551065.00
184 rdf:type schema:Person
185 sg:person.01264262573.40 schema:affiliation grid-institutes:grid.415479.a
186 schema:familyName Aoki
187 schema:givenName J
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264262573.40
189 rdf:type schema:Person
190 sg:person.01355201036.66 schema:affiliation grid-institutes:grid.415479.a
191 schema:familyName Kobayashi
192 schema:givenName T
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66
194 rdf:type schema:Person
195 sg:person.016213765552.09 schema:affiliation grid-institutes:grid.415479.a
196 schema:familyName Ohashi
197 schema:givenName K
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016213765552.09
199 rdf:type schema:Person
200 sg:person.0643633551.26 schema:affiliation grid-institutes:grid.415479.a
201 schema:familyName Igarashi
202 schema:givenName A
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643633551.26
204 rdf:type schema:Person
205 sg:person.0644344774.08 schema:affiliation grid-institutes:grid.415479.a
206 schema:familyName Haraguchi
207 schema:givenName K
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644344774.08
209 rdf:type schema:Person
210 sg:person.0677710136.43 schema:affiliation grid-institutes:grid.415479.a
211 schema:familyName Kakihana
212 schema:givenName K
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677710136.43
214 rdf:type schema:Person
215 sg:pub.10.1038/sj.bmt.1704816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039667048
216 https://doi.org/10.1038/sj.bmt.1704816
217 rdf:type schema:CreativeWork
218 grid-institutes:grid.415479.a schema:alternateName Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
219 Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
220 schema:name Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
221 Transfusion and Cell Therapy Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
222 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...